Transitioning from intramuscular (IM) to oral aripiprazole in patients with schizophrenia

被引：0
|
作者：
Daniel, D. [1 ]
Crandall, D. [1 ]
Manos, G. [1 ]
McQuade, R. [1 ]
机构：
[1] Bioniche Dev Inc, United BioSource Inc, Mclean, VA USA
来源：
SCHIZOPHRENIA BULLETIN | 2007年 / 33卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：426 / 427
页数：2
相关论文
共 50 条
  • [1] Transitioning from intramuscular (IM) to oral aripiprazole in patients with schizophrenia
    Daniel, D. G.
    Markovic, O.
    Crandall, D.
    Manos, G.
    McQuade, R. D.
    Gutierrez-Esteinou, R.
    Pikalov, A.
    Oren, D. A.
    EUROPEAN PSYCHIATRY, 2007, 22 : S124 - S125
  • [2] Transitioning from intramuscular to oral aripiprazole in patients with schizophrenia treated for acute agitation
    Daniel, D. G.
    Crandall, D.
    Manos, G.
    McQuade, R. D.
    Gutierrez-Esteinou, R.
    Pikalov, A. A.
    Oren, D. A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S287 - S287
  • [3] Pharmacokinetics and tolerability of intramuscular, oral and intravenous aripiprazole in healthy subjects and in patients with schizophrenia
    Boulton, David W.
    Kollia, Georgia
    Mallikaarjun, Suresh
    Komoroski, Bernard
    Sharma, Anjali
    Kovalick, Lawrence J.
    Reeves, Richard A.
    CLINICAL PHARMACOKINETICS, 2008, 47 (07) : 475 - 485
  • [4] Pharmacokinetics and Tolerability of Intramuscular, Oral and Intravenous Aripiprazole in Healthy Subjects and in Patients with Schizophrenia
    David W. Boulton
    Georgia Kollia
    Suresh Mallikaarjun
    Bernard Komoroski
    Anjali Sharma
    Lawrence J. Kovalick
    Richard A. Reeves
    Clinical Pharmacokinetics, 2008, 47 : 475 - 485
  • [5] Benefits of a second dose of intramuscular (IM) aripiprazole to control agitation in patients with schizophrenia or bipolar I disorder
    Citrome, L.
    Vester-Blokland, E.
    Archibald, D.
    McQuade, R.
    Pikalov, A.
    Oren, D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S253 - S253
  • [6] Strategies for Transitioning Therapy to Aripiprazole from Other Antipsychotics in Schizophrenia
    Wisniewski, Christopher S.
    Robert, Sophie
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (7-8) : 1097 - 1104
  • [7] Efficacy and tolerability of aripiprazole intramuscular as maintenance treatment in patients with paranoid schizophrenia
    Servan, B.
    Montes, A.
    Machin, M.
    Gomez, P.
    Garcia-Albea, J.
    Gonzalez, S.
    Ibanez, J.
    Moron, M. D.
    EUROPEAN PSYCHIATRY, 2017, 41 : S280 - S280
  • [8] Comparison of intramuscular aripiprazole and haloperidol with placebo in acutely agitated schizophrenia patients
    Dillenschneider, A
    Oren, D
    Marcus, R
    Kostic, D
    McQuade, R
    Iwamoto, T
    Manos, G
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S509 - S509
  • [9] Intramuscular aripiprazole in acute schizophrenia: A double-blfnd, placebo-controlled comparison with IM haloperidol
    McQuade, R
    Auby, P
    Oren, D
    Marcus, R
    Kostic, D
    Iwamoto, T
    Manos, G
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 57 - 58
  • [10] Response prediction in treatment of patients with schizophrenia after switching from oral aripiprazole to aripiprazole once-monthly
    Schoettle, Daniel
    Wiedemann, Klaus
    Correll, Christoph U.
    Janetzky, Wolfgang
    Friede, Michael
    Jahn, Holger
    Brieden, Andreas
    SCHIZOPHRENIA RESEARCH, 2023, 260 : 183 - 190
12345